Copyright
©The Author(s) 2022.
World J Crit Care Med. Jul 9, 2022; 11(4): 246-254
Published online Jul 9, 2022. doi: 10.5492/wjccm.v11.i4.246
Published online Jul 9, 2022. doi: 10.5492/wjccm.v11.i4.246
Table 2 Primary and secondary outcomes in sepsis, vasoplegic shock and septic shock 3.0 groups
| Sepsis | Vasoplegic shock | Septic shock 3.0 | Total | P | |
| (n = 51) | (n = 26) | (n = 41) | (n = 118) | ||
| Ventilator free-days at day 28 (mean ± SD) | 25.8 ± 6.4 | 11.4 ± 9.1 | 5.17 ± 8.9 | 15.4 ± 12.3 | < 0.001 |
| Vasopressor free-days at day 28 (mean ± SD) | 26.9 ± 5.5 | 15.7 ± 10.4 | 7.76 ± 10.2 | 17.8 ± 12 | < 0.001 |
| ICU length of stay, days (mean ± SD) | 6.86 ± 5.1 | 15.9 ± 8.2 | 24.3 ± 15.1 | 14.9 ± 12.8 | < 0.001 |
| In-hospital death rate (n) | 2 | 7 | 19 | 28 | < 0.001 |
- Citation: Cidade JP, Coelho L, Costa V, Morais R, Moniz P, Morais L, Fidalgo P, Tralhão A, Paulino C, Nora D, Valério B, Mendes V, Tapadinhas C, Povoa P. Septic shock 3.0 criteria application in severe COVID-19 patients: An unattended sepsis population with high mortality risk. World J Crit Care Med 2022; 11(4): 246-254
- URL: https://www.wjgnet.com/2220-3141/full/v11/i4/246.htm
- DOI: https://dx.doi.org/10.5492/wjccm.v11.i4.246